Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 30:13:1006076.
doi: 10.3389/fimmu.2022.1006076. eCollection 2022.

Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: A Brazilian study

Hugo L Corrêa  1 , Lysleine A Deus  1 , Thaís B Araújo  1 , Andrea L Reis  1 , Carlos E N Amorim  2 , André B Gadelha  1   3   4 , Rafael L Santos  1 , Fernando S Honorato  1 , Daisy Motta-Santos  5 , Carmen Tzanno-Martins  6 , Rodrigo V P Neves  1 , Thiago S Rosa  1
Affiliations

Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: A Brazilian study

Hugo L Corrêa et al. Front Immunol. .

Abstract

Background: The global burden of persistent COVID-19 in hemodialysis (HD) patients is a worrisome scenario worth of investigation for the critical care of chronic kidney disease (CKD). We performed an exploratory post-hoc study from the trial U1111-1237-8231 with two specific aims: i) to investigate the prevalence of COVID-19 infection and long COVID symptoms from our Cohort of 178 Brazilians HD patients. ii) to identify whether baseline characteristics should predict long COVID in this sample.

Methods: 247 community-dwelling older (>60 years) patients (Men and women) undergoing HD (glomerular filtration rate < 15 mL/min/1.73m2) with arteriovenous fistula volunteered for this study. All patients presented hypertension and diabetes. Patients were divided in two groups: without long-COVID and with long-COVID. Body composition, handgrip strength, functional performance, iron metabolism, phosphate, and inflammatory profile were assessed. Patients were screened for 11-months after COVID-19 infection. Results were considered significant at P < 0.05.

Results: We found that more than 85% of the COVID-19 infected patients presented a severe condition during the infection. In our sample, the mortality rate over 11-month follow was relatively low (8.4%) when compared to worldwide (approximately 36%). Long COVID was highly prevalent in COVID-19 survivors representing more than 80% of all cases. Phosphate and IL-10 were higher in the long COVID group, but only phosphate higher than 5.35 mg/dL appears to present an increased prevalence of long COVID, dyspnea, and fatigue.

Conclusion: There was a high prevalence of COVID-19 infection and long COVID in HD patients from the Brazilian trial 'U1111-1237-8231'. HD clinics should be aware with phosphate range in HD patients as a possible target for adverse post-COVID events.

Keywords: hemodialysis; inflammation; nephrology; phosphate; post-COVID.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Participant’s flow-chart.
Figure 2
Figure 2
Percent of long covid symptoms (A), frequency of men and women for each number of post-covid symptoms, and frequency of each symptom in hemodialysis patients (B). Percent of each post-covid symptoms (C) .
Figure 3
Figure 3
Heat map of the correlation matrix between phosphate ≥ 5.35 with each post COVID symptoms.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, et al. . Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study. Lancet Glob Health (2020) 8:e1003–17. doi: 10.1016/S2214-109X(20)30264-3 - DOI - PMC - PubMed
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (2020) 395:497–506. doi: 10.1016/S0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. . Factors associated with COVID-19-related death using OpenSAFELY. Nature (2020) 584:430–6. doi: 10.1038/s41586-020-2521-4 - DOI - PMC - PubMed
    1. Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q. Mortality in chronic kidney disease patients with COVID-19: A systematic review and meta-analysis. Int Urol Nephrol (2021) 53:1623–9. doi: 10.1007/s11255-020-02740-3 - DOI - PMC - PubMed
    1. Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, et al. . Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis (2021) 77:190–203.e191. doi: 10.1053/j.ajkd.2020.09.003 - DOI - PMC - PubMed

Publication types